Wuhan Huakang Century Medical Co., Ltd
Sponsor (lead underwriter) for announcement of IPO and gem listing results:
The application of Wuhan Huakang Century Medical Co., Ltd. for the initial public offering of no more than 26.4 million common shares (A shares) (hereinafter referred to as “this offering”) was examined and approved by the GEM Listing Committee of Shenzhen Stock Exchange on November 5, 2021, and approved to be registered by the CSRC’s zjxk [2021] No. 4121 on December 28, 2021, The sponsor (lead underwriter) of this offering is Huaying Securities Co., Ltd. (hereinafter referred to as “Huaying securities” or “sponsor (lead underwriter)”. The issuer’s stock is abbreviated as “Huakang medical” and the stock code is “301235”.
This offering will eventually adopt targeted placement to strategic investors (hereinafter referred to as “strategic placement”) Offline inquiry and placement to qualified investors (hereinafter referred to as “offline issuance”) and online pricing issuance to social public investors holding non restricted A-Shares and the market value of non restricted depositary receipts in Shenzhen market (hereinafter referred to as “online issuance”).
The number of shares issued by the initial strategic placement of this offering was 3.96 million shares, accounting for 15.00% of the number of shares issued. The issuer negotiated with the sponsor to determine that the issuing price of the shares is 39.30 yuan / share and the number of shares issued is 26.4 million. There is no transfer of old shares and all shares issued are new shares. The issuing price of this offering exceeds the median and weighted average of the offline investors’ quotation after excluding the highest quotation, as well as the securities investment fund, national social security fund, basic old-age insurance fund established through public offering after excluding the highest quotation The enterprise annuity fund established in accordance with the measures for the administration of enterprise annuity fund and the insurance fund quotation median and weighted average (hereinafter referred to as the “four values”) in accordance with the measures for the administration of the use of insurance funds, etc., whichever is lower, so the relevant subsidiaries of the sponsor need to participate in the investment.
According to the issuing price of this offering, the strategic placement investors of this offering are the special asset management plan of the issuer’s senior managers and core employees and Wuxi Guolian Innovation Investment Co., Ltd. (hereinafter referred to as “Guolian innovation investment”), a subsidiary of the sponsor. The final number of strategic placement shares in the special asset management plan for senior managers and core employees of the issuer is 788804 shares, accounting for about 2.99% of the number of shares issued this time; Wuxi Guolian Innovation Investment Co., Ltd., the relevant subsidiary of the parent company Guolian Securities Co.Ltd(601456) of Huaying Securities Co., Ltd., the sponsor of the issuance, finally placed 1056000 shares, accounting for about 4.00% of the issuance. Finally, the strategic placement of this issuance is the special asset management plan of the issuer’s senior managers and core employees and the relevant subsidiaries of the sponsor. The total amount of strategic placement is 1844804 shares, accounting for about 6.99% of the number of shares issued this time. The difference between the initial strategic placement and the final strategic placement is 2115196 shares, which are transferred back to offline issuance.
After the callback of strategic placement and before the launch of online and offline callback mechanism, the initial number of offline issuance was 1782319600 shares, accounting for 72.58% of the number issued after deducting the final number of strategic placement; The initial number of shares issued online was 6.732 million, accounting for 27.42% of the number issued after deducting the final strategic placement. According to the callback mechanism announced in the announcement of Wuhan Huakang Century Medical Co., Ltd. initial public offering and listing on the gem, the issuer and the sponsor (lead underwriter) decided to start the callback mechanism because the initial effective subscription multiple on the Internet was 10041.49666 times, higher than 100 times, 20% (rounded up to an integral multiple of 500 shares, i.e. 4.9115 million shares) of the number of shares issued in this public offering will be transferred back from offline to online. After the call back, the final number of offline shares issued was 12.911696 million, accounting for 52.58% of the total issued after deducting the final strategic placement; The final number of shares issued online was 11.6435 million, accounting for 47.42% of the total issued after deducting the final strategic placement. After the call back, the winning rate of this online pricing issuance is 0.0172242766%, and the subscription multiple is 5805.75905 times.
The online and offline subscription and payment work of this offering has been completed on January 21, 2022 (T + 2). 1、 Statistics of new share subscription
According to the data provided by Shenzhen Stock Exchange and Shenzhen Branch of China Securities Depository and Clearing Corporation, the sponsor (lead underwriter) made statistics on the subscription of new shares issued online and offline. The results are as follows:
(I) strategic placement
The issue price exceeds the lower of the median and weighted average of offline investors’ quotation after excluding the highest quotation and the median and weighted average of public offering products, pensions, social security funds, enterprise annuity funds and insurance funds after excluding the highest quotation. Therefore, the relevant subsidiaries of the sponsor need to participate in the follow-up investment.
The strategic placement objects of this issuance are the special asset management plan of the issuer’s senior managers and core employees and the relevant subsidiaries of the sponsor.
As of January 14, 2022 (T-3), strategic investors have paid their subscription funds in full and on time. According to the relevant agreements in the strategic placement investment agreement signed by the issuer, the sponsor (lead underwriter) and the strategic investors, the strategic placement results of this issuance are determined as follows:
Name of strategic investor allocated quantity (shares) allocated amount (yuan) sales restriction period (month)
Guolian Huakang medical staff’s participation in gem strategy
788804 3099997.20 12 placing collective asset management plan
Wuxi Guolian Innovation Investment Co., Ltd. 1056000 41500800.00 24
(II) online subscription of new shares
According to the data provided by Shenzhen Stock Exchange, the sponsor (lead underwriter) made statistics on the subscription of new shares issued online this time, and the results are as follows:
1. Number of shares subscribed by online investors (shares): 11449493
2. Subscription amount paid by online investors (yuan): 449965074.90
3. Number of online investors giving up subscription (shares): 194007
4. Subscription amount abandoned by online investors (yuan): 7624475.10
(III) offline subscription of new shares
1. Number of shares subscribed by offline investors (shares): 12911696
2. Subscription amount paid by offline investors (yuan): 507429652.80
3. Number of offline investors giving up subscription (shares): 0
4. Subscription amount abandoned by offline investors (yuan): 0
2、 Offline proportional restriction
The offline issuance part adopts the proportional sales restriction method, and the offline investors shall promise that the sales restriction period of 10% (rounded up) of the number of shares allocated to them is 6 months from the date of the issuer’s initial public offering and listing.
That is, among the shares allocated to each placing object, 90% of the shares are sold indefinitely and can be circulated from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange; The sales restriction period of 10% of the shares is 6 months, and the sales restriction period starts from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange.
When offline investors participate in the preliminary inquiry and quotation and offline purchase, they do not need to fill in the arrangement of the restricted sale period for the placing objects under their management. Once the quotation is made, it is deemed to accept the arrangement of the online restricted sale period disclosed in this announcement.
In this offering, the number of shares whose offline proportion is restricted for six months is 1293358, accounting for 10.02% of the total offline issuance and 4.90% of the total public offering.
3、 Underwriting by the recommendation institution (lead underwriter)
The number of shares abandoned by online and offline investors is underwritten by the sponsor (lead underwriter). The number of shares underwritten by the sponsor (lead underwriter) is 194007 shares, the underwriting amount is 7624475.10 yuan, and the underwriting proportion of the sponsor (lead underwriter) is 0.73%.
On January 25, 2022 (T + 4), the recommendation institution (lead underwriter) transferred the remaining underwriting funds to the issuer together with the strategic investors and the funds raised by online and offline issuance after deducting the recommendation and underwriting fee. The issuer will submit an application for share registration to China Securities Depository and Clearing Co., Ltd. Shenzhen Branch and register the underwritten shares to the securities account designated by the sponsor (lead underwriter).
4、 Contact information of sponsor (lead underwriter)
If the above investors have any questions about the issuance results announced in this announcement, please contact the sponsor (lead underwriter) of this issuance. The specific contact information is as follows:
Tel.: 010-58113001
Contact: capital market department
Issuer: sponsor (lead underwriter) of Wuhan Huakang Century Medical Co., Ltd.: Huaying Securities Co., Ltd. January 25, 2022 (this page has no text, which is the announcement on the results of initial public offering and listing on the gem of Wuhan Huakang Century Medical Co., Ltd.) (seal page)
Issuer: Wuhan Huakang Century Medical Co., Ltd. (this page has no text and is the seal page of the announcement on the results of initial public offering and listing on the gem of Wuhan Huakang Century Medical Co., Ltd.)
Sponsor (lead underwriter): Huaying Securities Co., Ltd. (mm / DD / yyyy)
